James Harn

James Harn

Director of Regulatory Affairs @ Bausch Health Companies Inc.

About

Experienced Regulatory Affairs Director with submission experience to the US FDA and Globally. Substantial experience managing change control Globally. Experienced with Sterile Small and Large Volume Parenterals of base solutions, small molecules, peptides and proteins in single, pharmacy bulk packages, and multi-dose formulations in a variety of packaging systems including multi-chamber large volume parenterial Nutritional products in PVC and non-PVC. Additional experience with modified release solid dosage forms and modified release oral liquids. Experience with human clinical trials for Bio-Equivalence and Bio-Availability, Pharmacodynamic and Pharmacokinetic studies. Experienced US Agent for FDA filings. Experienced in conducting Due Diligence reviews for Mergers and Acquisitions. Experienced as US Agent representative for foreign companies. Experienced with FDA meetings, Controlled Correspondence, FDA Drug Shortage negotiations, Orphan and rare disease products. Highly experienced in CMC, Labeling, product launches. Experienced with Post Market submissions supporting ANDA, and NDA products such as Annual Reports, CBE and PAS filings.

Country

-

City

United States

Industry

Pharmaceuticals

Skill

ICH, CAPA, Change Control, Validation, Regulatory Affairs, FDA, Regulatory Submissions, IND, Pharmacueticals, GMP, Formulation, Clinical Trials, ANDA, Pharmaceutical Industry, NDA, Sop, Regulatory Requirements, Aseptic Processing, Generic Programming, Pharmaceutics

Experience

Bausch Health Companies Inc.

Director of Regulatory Affairs

Bausch Health Companies Inc.

LinkedIn
2025-9 - Present · 1 yr 1 mo

United States

Azurity Pharmaceuticals

Director of Regulatory Affairs

Azurity Pharmaceuticals

LinkedIn
2023-6 - 2024-9 · 1 yr 4 mos

Due diligence and new product selection

Validus Pharmaceuticals

Senior Director of Regulatory Affairs

Validus Pharmaceuticals

LinkedIn
2021-10 - 2023-6 · 1 yr 9 mos

Head of Regulatory Affairs

XGen Pharmaceuticals DJB

Director of Regulatory Affairs

XGen Pharmaceuticals DJB

LinkedIn
2020-4 - 2021-8 · 1 yr 5 mos

Horseheads, New York, United States

Hepalink USA

Regional Director of Regulatory Affairs

Hepalink USA

2017-2 - 2020-1 · 3 yrs

Chicago, Illinois

Primary/Major Responsibilities: • Participate in project teams, performing scientific and technical oversight and review on development and regulatory documentation. • Ensure adherence to schedule for maintenance of approvals, including supplements to existing approvals. • Keep and maintain USDA permits for importation of raw materials. • Liaise with the Agency, monitor the progress of regulatory submissions, respond to queries and ensure that registration approvals are granted without undue delay. • Serve as the Regulatory Affairs Subject Matter Expert for the US business including evaluation of new and updated FDA policies/guidelines. • In a timely fashion, communicate what impact Agency changes will have on registration strategy. • Provide regulatory support and coordination during customer audits and regulatory inspections of the Hepalink facilities in the US and at Chinese sub- companies, as needed. • Provide training to Regulatory staff in China. • Interface with other departments such as Manufacturing, Product Development, Quality Control and Quality Assurance. • Work collaboratively with the regulatory group in China. • Conduct regulatory due diligence including evaluation and review of documentation for compliance with product licenses. • Provide input into project plans pertinent to regulatory activities. • Work with regulatory contract partners in US.

Emergent BioSolutions

Regulatory Affairs

Emergent BioSolutions

LinkedIn
2015-6 - 2017-1 · 1 yr 8 mos

Gaithersburg, MD

Lead regulatory activities and serve as regulatory representative on Product Development Teams to provide regulatory support and advice. Facilitate regulatory strategy development and implementation for Product Development Teams and lead regulatory submissions for products. Provide authoring, review, and coordination for quality submissions to regulatory agencies. Prepare for meetings, teleconferences, and other communications (including pre-read packages and/or other necessary documentation) with FDA and other global regulatory agencies. Educate teams regarding regulatory risks and implications for strategy and product development activities, and utilize technical knowledge and effectively apply regulations and guidelines to the product development process. • Experience with Orphan Drugs. • Advertising and Promotional Material Review Program Lead • Technical Due Diligence Review member for Mergers and Acquisitions. • Lead development of regulatory strategy for Product Development Teams • Lead preparation of regulatory submissions including pre-IND and formal meetings with FDA, INDs, Annual Reports, and routine correspondence • Monitor product-related corporate activities for regulatory compliance, including CMC, nonclinical, and clinical plans and practices • Manage and lead a group of regulatory professionals within the Regulatory department • Provide critical review of documentation supporting regulatory applications • Plan, coordinate, prepare and lead meetings and teleconferences with regulatory agencies • Assist in interactions with FDA and other regulatory agencies. • Build professional relationships with FDA project managers and other key personnel, as appropriate. • Communicate with outside regulatory agencies regarding submissions and provide company representation with regulatory agencies to obtain expeditious approval and maintain post-approval compliance • Provide regulatory intelligence for project teams and product development plans.

Xellia Pharmaceuticals

Director Of Regulatory Affairs

Xellia Pharmaceuticals

LinkedIn
2013-3 - 2015-5 · 2 yrs 3 mos

US Agent representing Xellia to the FDA. Achieved the companies first three ANDA approvals. Conducted Due Diligence reviews for Mergers and Acquisitions. Responsible for filing new ANDA's, 505(b)(2) NDA's and for Portfolio Development Product filing Strategies.

Neos Therapeutics

Director Of Regulatory Affairs

Neos Therapeutics

2012-8 - 2013-3 · 8 mos

Grand Prairie, TX

Filed 505(b)(2) NDA's, change control assessments, IND updates for DEA Controlled drugs.

Fresenius Kabi USA

Manager Regulatory Affairs

Fresenius Kabi USA

LinkedIn
2011-5 - 2012-8 · 1 yr 4 mos

Schaumburg, IL

Regional Business Support filing new ANDA and NDA submissions and Life Cycle Maintenance filings of Annual Reports, CBE and PAS supplements. Also managed briefing packages and attended Type B and Type C FDA meetings.

Baxter International Inc.

Manager, Regulatory Affairs

Baxter International Inc.

LinkedIn
2006-1 - 2011-5 · 5 yrs 5 mos

Global Regulatory Affairs Manager supporting the Nutrition business for currently marketed products and development products.

Education

Keller Graduate School of Management of DeVry University

Keller Graduate School of Management of DeVry University

LinkedIn

Business

1991 - 1994 · 3 yrs

MBA with Certificate in HR

James Harn's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.